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Abstract ARC is a caspase recruitment domain-containing
molecule that plays an important role in the regulation of apo-
ptosis. We examined ARC expression during neuronal cell death
following ischemic injury in vivo and in vitro. After exposure to
transient global ischemic conditions, the expression of ARC was
substantially reduced in the CA1 region of hippocampus in a
time-dependent manner with concomitant increase of TUNEL-
positive cells. Quantitative analysis using Western blotting ex-
hibited that most of ARC protein disappeared in the cultured
hippocampal neurons exposed to hypoxia for 12 h and showing
60% cell viability. Forced expression of ARC in the primary
cultures of hippocampal neurons or B103 neuronal cells signi¢-
cantly reduced hypoxia-induced cell death. Further, the C-ter-
minal P/E rich region of ARC was e¡ective to attenuate hy-
poxic insults. These results suggest that down-regulation of
ARC expression in hippocampal neurons may contribute to neu-
ronal death induced by ischemia/hypoxia.
1 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
Key words: Apoptosis repressor with caspase recruitment
domain; Ischemia; Hypoxia; Hippocampal neuron;
Rat brain
1. Introduction
Degeneration of neurons is the fundamental process respon-
sible for the clinical manifestations of many di¡erent neuro-
phathological disorders, including Alzheimer’s disease, Par-
kinson’s disease, and epilepsy [1,2]. The neurodegeneration
mechanism in such disorders is not well known. However,
one of the principal pathways controlling cell death is the
regulation of protein^protein interaction, such as the death
domain, the death e¡ector domain, and the caspase recruit-
ment domain (CARD) [3^5].
ARC (apoptosis repressor with CARD) is an apoptotic reg-
ulatory protein and expressed in a majority of myocytes in the
heart and skeletal muscle. It contains two domains: C-termi-
nal P/E rich domain and N-terminal CARD that is linked to
caspase inhibition, such as caspase-2 and -8 [6]. Recent studies
reported that overexpression of ARC inhibited hypoxia- and
oxidant stress-induced cell death in the cardiac myocytes by
preserving mitochondria function [6,7], while a proapoptotic
role of ARC was also reported in serum withdrawal-induced
death of PC12 cells [8]. Alternative splicing variants of ARC
and cell death-induced subcellular translocalization of ARC
to intracellular membrane or nuclei suggest their diverse roles
in the death signaling events [9,10]. However, the mechanism
by which ARC interferes with the cell death is not clearly
de¢ned yet.
In the present study, we have examined the regulation of
ARC expression after transient global cerebral ischemia in rat
brain and found the protective role of ARC expression in the
cultured hippocampal neurons during hypoxia.
2. Materials and methods
2.1. Transient global cerebral ischemia in rats and immunostaining
All animal experiments were performed in accordance with the
Guide of Ulsan University College of Medicine for Care and Use of
Laboratory Animals. Under halothane anesthesia, common carotid
arteries of male Sprague^Dawley rats weighing 300^350 g were bilat-
erally occluded with vascular clamps and mean arterial blood pressure
was lowered to 50E 5 mm Hg by withdrawing blood from the femoral
artery. After 12 min, the blood perfusion was recovered by removing
clips and re-infusing the blood. At 24 and 72 h after ischemia, brains
were removed and quickly frozen in liquid nitrogen. Coronal brain
sections containing hippocampi were prepared with cryostat (thick-
ness, 10 Wm) and put onto the slide glass pre-coated with poly-L-lysine
(Sigma). After incubation with anti-ARC antibody, sections were in-
cubated with avidin^biotin complex (ABC kit, Santa Cruz Biotech.).
To identify neuronal death, the brain sections were stained with TU-
NEL assay (Oncor).
2.2. Cell culture
Primary hippocampal cell cultures were dissected from gestation
stage E17 of rat. Hippocampi were incubated at 37‡C for 15 min in
trypsin/EDTA (Gibco BRL) and triturated with a glass pipette to
dissociate cells. After centrifugation at 2000 rpm for 2 min, the pellet
was resuspended and plated at the density of 3U105 cells/ml in four-
well plates previously coated with poly-L-lysine in Dulbecco’s modi-
¢ed Eagle’s medium (DMEM) with 5% fetal bovine serum (FBS) and
5% horse serum (Equitech-bio, Inc.). Cells were allowed to attach for
45 min at 37‡C with 5% CO2 and cultured with serum-free neurobasal
medium with B27 supplement, 0.5 mM L-glutamine, and penicillin/
streptomycin for 5 days (all from Gibco BRL). B103 cells were cul-
tured in DMEM supplemented with 10% FBS.
2.3. Hypoxia induction and cell viability assay
Hypoxia was achieved by culturing the cells in serum- and glucose-
de¢cient salt solution (116 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4W7
H2O, 1 mM NaH2PO4WH2O, 1.8 mM CaCl2, 26 mM NaHCO3) in an
0014-5793 / 03 / $22.00 M 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
doi:10.1016/S0014-5793(03)00444-7
*Corresponding author. Fax: (82)-62-970 2484.
E-mail address: ykjung@kjist.ac.kr (Y.-K. Jung).
Abbreviations: CARD, caspase recruitment domain; ARC, apoptosis
repressor with CARD; GFP, green £uorescence protein
FEBS 27261 7-5-03
FEBS 27261FEBS Letters 543 (2003) 170^173
air-tight plexiglas chamber (BBL1, Becton Dickinson) for 0^24 h at
37‡C as previously described [11]. Cells were counted before and after
exposure to hypoxia and stained with trypan blue to evaluate cell
viability. The mortality of the neurons transfected with green £uores-
cence protein (GFP)-fusion construct was assessed as a percentage of
trypan blue-positive per £uorescence-positive staining.
2.4. DNA construction
EcoRI and BamHI fragments encoding full-length (amino acids 1^
208), N-terminal domain of ARC (amino acids 1^98), or C-terminal
domain (amino acids 99^208) were ampli¢ed by polymerase chain
reaction and subcloned into pEGFP-N1.
2.5. DNA transfection and stable cell line generation
After culturing for 5 days, hippocampal neurons were transfected
with 1 Wg of control vector (pEGFP) or ARC expression plasmids
using LipofectAMINE PLUS1 Reagent according to the protocol
provided by Gibco BRL. After 5 h, the transfected neurons were
replaced in neurobasal medium supplemented with B27 and glutamine
(all from Gibco BRL). B103 cells were transfected with pEGFP
or pEGFP-ARC using LipofectAMINE PLUS1 and replaced in
DMEM/10% FBS with G418 sulfate (800 Wg/ml, Gibco BRL) for
3 weeks. Colonies derived from a single cell were picked and expanded
as stable cell lines.
2.6. Western blotting
Cell extracts (20 Wg) prepared from primary cultures or cell lines
exposed to hypoxia were separated by sodium dodecyl sulfate^poly-
acrylamide gel electrophoresis and transferred to nitrocellulose mem-
brane. Proteins were detected using primary antibodies, horseradish
peroxidase-linked secondary antibody, and enhanced chemilumines-
cence system (ECL1) (Amersham-Pharmacia Biotech.).
3. Results
3.1. Reduced expression of ARC in the rat brain after transient
global ischemia
To examine whether ARC was implicated in ischemic insult
of rat brain, the expression of ARC was investigated in the
hippocampus of normal and ischemic brain (Fig. 1). A coro-
nal section of hippocampus was stained with anti-ARC anti-
body (Fig. 1a^c) or TUNEL assay (Fig. 1d^f, small box). An
intensive and strong cellular expression pattern of ARC was
observed in hippocampus of sham-operated rats (Fig. 1a).
After transient global ischemia, the ARC protein level clearly
decreased at 24 h and almost disrupted at 72 h in the CA1 and
CA2 regions of the hippocampus (Fig. 1b,c, arrows), but not
in dentate gyrus (Fig. 1b,c, arrowheads). The numbers of
ARC-positive pyramidal neurons in the CA1 of hippocampus
were less in response to ischemia than control (Fig. 1d^f). In
contrast, TUNEL assay showed that apoptosis-positive neu-
rons were observed at 72 h after induction of ischemia (Fig.
1d^f, small boxes), indicating that down-regulation of ARC in
the hippocampal neurons damaged by ischemic insult inverse-
ly correlates with the appearance of dying cells.
3.2. Reduced expression of ARC in cultured hippocampal
neurons after hypoxia
ARC expression was further assessed in the cultured hippo-
campal neurons undergoing hypoxia-induced neuronal death.
Primary hippocampal neurons were prepared from gestation
stage E17 of rat and exposed to hypoxia for the indicated
times. Hypoxic neurons were evident at 12 h with the mor-
phological characteristics by the appearance of a rough, dark-
ened soma and loss of phase brightness (Fig. 2A,b), while
viable neurons were round to oval and showed smooth
soma and intact neurites (Fig. 2A,a). Approximately 50% of
neurons were stained by trypan blue at 12 h after induction of
hypoxia and 80% of hypoxic neurons were evident at 24 h
compared to control neurons (Fig. 2B). Western blot analysis
showed that the expression level of ARC decreased in a time-
dependent manner during hypoxia. Approximately 50% of
ARC protein level was apparently reduced in the neurons
Fig. 1. Correlation between ARC expression and neuronal cell death
in the hippocampus after transient global ischemia. Upper panel,
low-magni¢cation photographs of anti-ARC antibody-stained hippo-
campi of sham-operated rat (a) and rat at 24 h (b) and 72 h (c)
after reperfusion. Arrowheads indicate dentate gyrus. Scale bar, 200
Wm. Lower panel, high-power photographs of CA1 pyramidal neu-
rons (arrows, upper panel) stained with anti-ARC antibody and
showing reduction of ARC immunoreactivity. Typical pycnotic
bodies were observed in most of the neurons at 72 h (f) compared
to sham control (d) or 24 h after ischemic damage (e) (small boxes,
TUNEL staining). Scale bar, 100 Wm.
Fig. 2. Quantitative analysis of ARC expression in the cultured hip-
pocampal neurons under hypoxic insults. Cultured hippocampal
neurons were left untreated (control) or exposed to hypoxic insult
for the indicated times. Cell viability was determined by trypan blue
exclusion assay. The morphology of neurons (A), neuronal cell
death (B, upper panel), and Western blotting (B, lower panel) were
assessed.
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exposed to hypoxia for 6 h and most ARC protein disap-
peared at 24 h compared to control cultures, indicating that
ARC protein disappears in dying hippocampal neurons.
3.3. Hippocampal neurons expressing ARC are resistant to
hypoxia-induced cell death
To examine whether the reduction of ARC protein is func-
tionally associated with ischemia-induced death of hippocam-
pal neurons, the protective function of ARC expression was
addressed by gene-transfer analysis. The cultured hippocam-
pal neurons were transiently transfected with expression plas-
mid encoding full-length ARC fused to GFP or control DNA.
Two days after DNA transfection, the vulnerability to neuro-
nal death triggered by hypoxia was analyzed based on the
morphology and trypan blue staining of the GFP-positive
neurons. Under normoxia, the viabilities of hippocampal neu-
rons expressing ARC-GFP were similar with those of the
control neurons (Fig. 3A). On the contrary, the hippocampal
neurons transfected with full-length ARC exhibited signi¢-
cantly increased viability in response to hypoxia, compared
to control neurons. When the neurons were exposed to hyp-
oxia for 10 h, the mortality of neurons expressing ARC was
higher than that of the control neurons; the viability was
increased from 53% to 80%. These results indicate that
ARC suppresses hypoxia-induced neuronal death.
Deletion mutants containing either only the N-terminal
CARD or the C-terminal P/E rich domain of ARC were gen-
erated to de¢ne a domain responsible for the suppression of
hypoxia-induced cell death. Hippocampal neurons transiently
expressing the C-terminal P/E rich domain of ARC became
morphologically shrunk at 5 h after hypoxia but were desen-
sitized to hypoxia as examined with trypan blue staining (Fig.
3B). In contrast, the N-terminal CARD of ARC showed a
di¡erent cellular distribution pattern from the C-terminal
P/E domain, localized mainly in the cell body but not in the
neurites of the transfected neurons and upon hypoxic condi-
tion, did not show such inhibitory e¡ects as full-length ARC
or the C-terminal P/E domain. These results suggest that the
inhibitory activities of ARC during ischemia/hypoxia reside in
the C-terminal P/E rich domain of ARC.
3.4. B103 neuronal cells overexpressing ARC reduce
hypoxia-induced cell death
To further examine the inhibitory role of ARC in hypoxia-
induced neuronal cell death, we generated B103 neuronal cell
lines overexpressing full-length ARC or control DNA. We
selected for study three clones of B103 cells stably overex-
pressing di¡erent levels of ARC and then analyzed the vulner-
ability of those cells to hypoxia (Fig. 4). Forced expression of
ARC in B103 cells signi¢cantly decreased hypoxia-induced
cell death in comparison with the vector-transfected control
cells, while ARC itself did not a¡ect the basal level of cell
viability (Fig. 4), con¢rming that ARC expression reduces
death of neuronal cells exposed to hypoxia.
4. Discussion
Transient global ischemic insults in the brain can result in
the selective death of certain neurons, for example, the pyra-
midal neurons in the CA1 region of the hippocampus. In the
present study, we demonstrate for the ¢rst time that ARC
protein is also detected in the hippocampal neurons and its
expression level is reduced in hippocampal neurons following
ischemic insults. In addition, the protective e¡ects of ARC
overexpression on hypoxic insults enabled us to propose
that ARC protein was reduced in the a¡ected neurons as a
necessary step leading to neuronal death during ischemia/hyp-
Fig. 3. Transient expression of the C-terminal P/E rich domain of
ARC protects hippocampal neurons from hypoxia-induced cell
death. A: Hippocampal neurons were transiently transfected with
pEGFP or pEGFP-ARC, and then exposed to hypoxia for the indi-
cated times. The mortality of the GFP-positive neurons was scored
using trypan blue staining. Bars depict meansES.E.M. from three
independent experiments (total number of the transfected neurons,
20^30 cells/transfection). B: The hippocampal neurons expressing ei-
ther the C-terminus (ARC-CT) or the N-terminus of ARC (ARC-
NT) were exposed to hypoxia for 5 h and stained with trypan blue
(TB, arrowheads). The cells were visualized under a £uorescence
microscope. Scale bar, 20 Wm.
Fig. 4. Stable expression of ARC inhibits hypoxia-induced death of
B103 neuronal cells. B103 cells were permanently transfected with
pcDNA (control) or pcDNA-ARC, and examined for the expression
level of ARC with Western blot analysis (upper panel). Three di¡er-
ent stable clones (#1, #35, and #43) were exposed to hypoxia for
the indicated times and cell viability was determined (lower panel).
Values represent the meansES.E.M. of three separate experiments.
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oxia. These results are reinforced by the previous observation
that in cardiac cell lines, ARC exerted protective properties in
hypoxia-induced apoptosis [7].
Under ischemic damage, plummeting of cellular ATP level
impairs membrane ion-motive ATPases to remove Naþ and
Ca2þ from the cell, allowing membrane depolarization and
promoting activation of synaptic glutamate receptors for mas-
sive calcium in£ux and the downstream activation of delete-
rious events including the activation of catabolic enzymes and
over-production of free radicals [12^14]. The mechanism by
which ARC inhibits neuronal cell death remains unclear.
However, several mechanisms can be proposed to explain
how ARC protects neuronal cells from ischemic insults.
ARC may a¡ect the activity of the molecule involved in the
apoptosis cascade, such as caspases [15,16] or members of the
Bcl-2 family [17] that contributed to ischemic brain damage as
evidenced by pharmacological or genetic manipulations. ARC
as an interacting molecule with caspase-8 may inhibit ische-
mia/hypoxia-mediated activation of caspase as initially pro-
posed by Koseki and coworkers in skeletal muscle [6]. Also,
ARC may block caspase-independent events associated with
apoptosis, such as hydrogen peroxide-induced cytochrome c
release [18].
Alternatively, the notion that the C-terminal P/E rich do-
main of ARC inhibited ischemia/hypoxia-induced neuronal
death led us to propose that the P/E rich domain, but not
CARD region, functions to interfere cell death. We found that
the C-terminal P/E domain was able to bind to calcium and
a¡ect intracellular calcium signaling (D. Jo and Y. Jung,
manuscript in preparation). Given the importance of cytosolic
free calcium during ischemia/hypoxia, the P/E domain of
ARC may sequester cytosolic free calcium and protect neuro-
nal cells from ischemic damage. Thus, the ARC level is im-
portant for the regulation of ischemia/hypoxia-mediated dam-
age and the reduction of ARC expression in the ischemic
brain in vivo may increase neuronal cell death. Further under-
standing of the inhibitory mechanism controlling neuronal
death during ischemia needs to be established.
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